Evidence map›Paper›PMID 37945902›Full record

ArticleNature genetics2023

Most large structural variants in cancer genomes can be detected without long reads.

Zi-Ning Choo, Julie M Behr, Aditya Deshpande, Kevin Hadi, Xiaotong Yao, Huasong Tian, Kaori Takai, George Zakusilo, Joel Rosiene, Arnaud Da Cruz Paula and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. HOROSCOPE: Decoding human centromere architecture from short reads usingbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. A complete human pancreatic cancer genome.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Zi-Ning ChooNew York Genome Center, New York, NY, USA.
Julie M BehrNew York Genome Center, New York, NY, USA.
Aditya DeshpandeNew York Genome Center, New York, NY, USA.
Kevin HadiNew York Genome Center, New York, NY, USA.
Xiaotong YaoNew York Genome Center, New York, NY, USA.
Huasong TianNew York Genome Center, New York, NY, USA.
Kaori TakaiLaboratory of Cell Biology and Genetics, Rockefeller University, New York, NY, USA.
George ZakusiloLaboratory of Cell Biology and Genetics, Rockefeller University, New York, NY, USA.
Joel RosieneNew York Genome Center, New York, NY, USA.ORCID 0000-0002-8610-370X
Arnaud Da Cruz PaulaMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-7694-8760
Britta WeigeltMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9927-1270
Jeremy SettonMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Nadeem RiazMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9873-5862
Simon N PowellMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-8183-4765
Klaus BusamMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-0888-9601
Alexander N ShoushtariMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Charlotte AriyanMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Jorge Reis-FilhoMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-2969-3173
Titia de LangeLaboratory of Cell Biology and Genetics, Rockefeller University, New York, NY, USA.ORCID 0000-0002-9267-367X
Marcin ImielińskiNew York Genome Center, New York, NY, USA. mski@mskilab.org.ORCID 0000-0002-2211-4741
Memorial Sloan Kettering Cancer Center · USCornell University · USRockefeller University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Targeting Polθ to Overcome PARP Inhibitor Resistance in Homologous Recombination Deficient Breast CancerP50CA247749 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Sarat Chandarlapaty, Simon N. Powell · 2020 to 2026
$16.3M
Genome instability in cancer: telomeres and DNA repairR35CA210036 · NCI · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 2016 to 2026
$10.8M
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor ProfilesU24CA264032 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELEMENTO, OLIVIER, ROBINE, NICOLAS · 2021 to 2025
$2.0M
Inferring the structure and evolution of tandem duplication towersF30CA268747 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOO, ZI-NING · 2022 to 2024
$158k
Towards a Simulation of Cancer Genomes for Benchmarking Structural Variant AlgorithmsF31CA232465 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HADI, KEVIN MATTHEW · 2018 to 2020
$135k
NCI NIH HHS F30 CA268747NCI NIH HHS F31 CA232465NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA247749NCI NIH HHS R35 CA210036NCI NIH HHS U24 CA264032NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Short-read sequencing is the workhorse of cancer genomics yet is thought to miss many structural variants (SVs), particularly large chromosomal alterations. To characterize missing SVs in short-read whole genomes, we analyzed 'loose ends'-local violations of mass balance between adjacent DNA segments. In the landscape of loose ends across 1,330 high-purity cancer whole genomes, most large (>10-kb) clonal SVs were fully resolved by short reads in the 87% of the human genome where copy number could be reliably measured. Some loose ends represent neotelomeres, which we propose as a hallmark of the alternative lengthening of telomeres phenotype. These pan-cancer findings were confirmed by long-molecule profiles of 38 breast cancer and melanoma cases. Our results indicate that aberrant homologous recombination is unlikely to drive the majority of large cancer SVs. Furthermore, analysis of mass balance in short-read whole genome data provides a surprisingly complete picture of cancer chromosomal structure.

Indexed as

Breast NeoplasmsGenomicsChromosome AberrationsFemaleGenome, HumanGenomic Structural VariationHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNA

Identifiers

PMID37945902
PMCPMC10703688
OpenAlexW4388540987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.